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Citrullination of HP1γ chromodomain affects 
association with chromatin
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Abstract 
Background: Stem cell differentiation involves major chromatin reorganisation, heterochromatin formation and 
genomic relocalisation of structural proteins, including heterochromatin protein 1 gamma (HP1γ). As the principal 
reader of the repressive histone marks H3K9me2/3, HP1 plays a key role in numerous processes including heterochro-
matin formation and maintenance.
Results: We find that HP1γ is citrullinated in mouse embryonic stem cells (mESCs) and this diminishes when cells dif-
ferentiate, indicating that it is a dynamically regulated post-translational modification during stem cell differentiation. 
Peptidylarginine deiminase 4, a known regulator of pluripotency, citrullinates HP1γ in vitro. This requires R38 and R39 
within the HP1γ chromodomain, and the catalytic activity is enhanced by trimethylated H3K9 (H3K9me3) peptides. 
Mutation of R38 and R39, designed to mimic citrullination, affects HP1γ binding to H3K9me3-containing peptides. 
Using live-cell single-particle tracking, we demonstrate that R38 and R39 are important for HP1γ binding to chromatin 
in vivo. Furthermore, their mutation reduces the residence time of HP1γ on chromatin in differentiating mESCs.
Conclusion: Citrullination is a novel post-translational modification of the structural heterochromatin protein HP1γ 
in mESCs that is dynamically regulated during mESC differentiation. The citrullinated residues lie within the HP1γ chro-
modomain and are important for H3K9me3 binding in vitro and chromatin association in vivo.
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Introduction
Embryonic stem cells (ESCs) are pluripotent cells with 
the unique ability to self-renew and differentiate into 
nearly every cell type of the body. This plasticity is main-
tained by a distinct nuclear architecture with particu-
lar epigenetic signatures including enrichment of active 
chromatin marks and dynamic binding of structural 
chromatin proteins [1, 2].
HP1 was originally described as a dominant suppres-
sor of position-effect variegation in Drosophila mela-
nogaster [3]. The mammalian HP1 protein family consists 
of three members: HP1α, β and γ. As the main reader of 
repressive histone marks H3K9me2/3, HP1 is a key fac-
tor in heterochromatin formation and maintenance 
[4, 5]. However, whilst HP1α and β are mainly associ-
ated with constitutive heterochromatic regions, HP1γ is 
predominantly found in euchromatin [6, 7], within the 
transcribed regions of active genes. Here, it regulates 
transcriptional elongation [8–11] and co-transcriptional 
mRNA processing [7, 12].
HP1γ plays important roles in developmental processes 
and cell fate decisions [13]. For instance, depletion of 
HP1γ in mESCs results in endodermal and neuronal dif-
ferentiation defects [14, 15]. Interestingly, HP1γ is differ-
entially localised during mESC differentiation. In mESCs, 
it predominantly occupies gene bodies, whereas in neu-
ronal precursor cells (NPCs), it is significantly enriched 
at the promoters of active genes [14, 16]. This indicates a 
direct role for HP1γ regulating transcription during dif-
ferentiation. However, little is known concerning how 
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the recruitment of HP1γ and its association with specific 
genomic loci is regulated.
Peptidyl citrullination (deimination) is the post-transla-
tional conversion of an arginine (R) residue within a pro-
tein to the non-encoded amino acid citrulline. This leads 
to loss of a positive charge and a reduction in hydrogen 
bonding ability. It is mediated by a vertebrate-specific 
family of enzymes called peptidylarginine deiminases 
(PADIs) which are associated with the development of 
different pathological conditions such as autoimmun-
ity, cancer and neurodegenerative diseases [17]. The 
deiminases are widely expressed in mammalian tissues, 
and PADIs 1, 2 and 4 have been reported to localise to 
the nucleus [18–20]. Histones are the best-characterised 
nuclear targets of PADI enzymes, and their citrullination 
is directly linked to transcriptional regulation [18–22].
We previously identified a role for PADI4 during repro-
gramming and ground state pluripotent stem cells [22], 
where the deiminase regulates key pluripotency genes 
via a mechanism involving citrullination of H1.2. This 
results in its eviction from chromatin and global chroma-
tin decompaction. Here, we report that the chromodo-
main of HP1γ is also citrullinated in mESCs, at R38 and 
R39. We show that binding of HP1γ to peptides bearing 
H3K9me3 enhances its citrullination by PADI4 in  vitro. 
Furthermore, mutations in HP1γ designed to mimic the 
loss of charge caused by citrullination inhibit binding of 
HP1γ to peptides harbouring H3K9me3 and reduce its 
residence time on chromatin in differentiating mESCs. 
We also observe a reduction in the level of HP1γ citrulli-
nation upon mESC differentiation. These results support 
a role for citrullination as a mechanism to regulate HP1γ 
chromatin association during stem cell differentiation.
Results
HP1γ chromodomain is citrullinated in vivo
We previously used tandem mass spectroscopy (MS/
MS) to identify citrullinated proteins in mESCs [22]. We 
have now performed a more thorough interrogation of 
these data using an improved search algorithm to iden-
tify additional citrullinated chromatin-associated pro-
teins (Christophorou et  al., manuscript in preparation). 
This analysis detected two citrullinated sites within the 
chromodomain of HP1γ (Fig. 1a, Additional file 1: Figure 
S1A). More specifically, the presence of immonium ions 
unique for citrulline (referred to as Im/(Cit) at m/z 130) 
and arginine (referred to as Im/(Arg) at m/z 129) was 
detected in two peptides (Fig. 1b, c). This strongly implies 
the presence of both citrulline and arginine in these 
peptides. In the first peptide, citrullination of R38 was 
identified with a localisation probability of 0.71 (Fig. 1b, 
Additional file 1: Figure S1B). MS/MS analysis of the sec-
ond peptide identified citrullination at either R38 or R39, 
each with a localisation score of 0.50 (Fig. 1c, Additional 
file 1: Figure S1C). Taken together, our MS data indicate 
that HP1γ is citrullinated in mESCs at either R38 or R39, 
most likely the former. However, it is possible that both 
R38 and R39 are citrullinated.
Efficient binding of HP1γ to H3K9me3 requires R38 
and R39
Citrullination of arginine neutralises the charge of the 
side-chain. Given that R38 and R39 are located within 
the chromodomain of HP1γ, we investigated whether 
they are important for binding H3K9me3. We generated 
recombinant full-length mouse HP1γ proteins, either 
wild type (WT) or with alanine substitutions at amino 
acids 38 and 39 to mimic citrullination (Additional file 1: 
Figure S1D). In vitro peptide pulldown assays were used 
to test the binding of HP1γ to unmethylated H3(1–16) 
or methylated H3K9me3(1–16) peptides. As expected, 
HP1γ specifically binds to H3K9me3 peptides (Fig.  2a, 
Additional file  2: Figure S2A). In contrast, we observed 
that binding of double alanine mutant HP1γR38/9A to 
H3K9me3 peptides was significantly reduced (Fig.  2a, 
Additional file 2: Figure S2A).
We confirmed these results by assessing real-time bind-
ing kinetics of GST-HP1γ proteins to immobilised H3 or 
H3K9me3 peptides using bio-layer interferometry (BLI). 
As expected, HP1γWT binds exclusively to H3K9me3 
peptides (Fig.  2b, Additional file  2: Figure S2B and C, 
Additional file 3: Table S1), which agrees with previously 
published analyses [23]. We repeated these analyses at 
a range of different GST protein concentrations (Addi-
tional file 2: Figure S2C). Again, the HP1γR38/9A mutant 
protein displayed a distinctly different kinetic behaviour 
compared to the WT protein (Fig.  2b, Additional file  2: 
Figure S2B and C, Additional file 3: Table S1). Binding of 
HP1γR38/9A appears to begin to plateau at significantly 
lower amounts compared to the WT protein. These 
results confirm the data obtained from pulldown assays 
(Fig. 2a, Additional file 2: Figure S2A). However, a more 
thorough biophysical analysis is required to fully assess 
the kinetic behaviour of HP1γR38/9A molecules binding 
to H3K9me3 sites.
Interestingly, mutation of both R38 and R39 to lysine 
(R38/9K), which retains the positive charge at these posi-
tions, maintained binding to H3K9me3 peptides in pull-
down assays (Additional file 2: Figure S2A), as well as in 
BLI measurements (Additional file 2: Figure S2B and C, 
Additional file 3: Table S1).
PADI4 citrullinates HP1γ in vitro
PADI4 is nuclear in mESCs, and previous studies 
from our laboratory, as well as others, identified sev-
eral chromatin-associated (histone and non-histone) 
Page 3 of 17Wiese et al. Epigenetics & Chromatin           (2019) 12:21 
substrates of the deiminase [21, 22, 24, 25]. Therefore, 
we next asked whether recombinant purified PADI4 cit-
rullinates HP1γ in in  vitro citrullination assays. Enzy-
matic activity of recombinant PADI4 was confirmed 
by citrullination of histone H3—a known substrate of 
PADI4 [18] (Additional file 4: Figure S3A and B). Using 
an anti-peptidyl-citrulline antibody, we found that 
PADI4 citrullinates HP1γ in  vitro (Fig.  3a, Additional 
file  4: Figure S3C). To determine whether PADI4 cit-
rullinates HP1γ at positions 38 and 39, we substituted 
amino acid R38 and/or R39 with lysine. Citrullination 
of HP1γ was abolished in both R38K and R39K mutant 
proteins (Fig.  3a, Additional file  4: Figure S3C), indi-
cating that (i) both arginines are required for PADI4 to 
target HP1γ, and (ii) R38 and/or R39 is citrullinated by 
PADI4 in vitro. Specificity of HP1γ citrullination at res-
idues R38 and R39 was further confirmed by using an 
affinity purified polyclonal site-specific antibody that 
specifically recognises HP1γ citrullination at residues 
R38 and R39 (Additional file  4: Figure S3D). Like the 
anti-peptidyl-citrulline antibody, the HP1γ-R38/9Cit 
antibody specifically detects citrullination of wildtype 
HP1γ, but not R38/9K mutant proteins in in  vitro cit-
rullination extracts (Additional file  4: Figure S3E and 
F), further verifying that HP1γ is citrullinated at R38 
and R39 in vitro.
Interestingly, the addition of methylated H3K9me3 
peptides to the in  vitro citrullination assay increased 
HP1γ citrullination by PADI4 by approximately twofold 
(Fig.  3b, Additional file  4: Figure S3G). The enhanced 
citrullination appears specific because it was abolished 
when the HP1γR38/9K mutant protein was used as a sub-
strate (Fig. 3b, Additional file 4: Figure S3G), even though 
this protein binds H3K9me3 peptides with similar affin-
ity to the WT protein (Additional file 2: Figure S2). We 
conclude that PADI4 preferentially citrullinates HP1γ 
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Fig. 1 HP1γ chromodomain is citrullinated in vivo. a The left panel is a schematic illustration of the functional domain structure of mouse HP1γ. 
Chromodomain (CD, blue), hinge region (HR, orange), chromoshadow domain (CSD, green) and N-terminal extension (grey) are indicated. Above 
is a multiple sequence alignment of mouse HP1 paralogue chromodomain amino acid (aa) sequences using Clustal Omega. CD secondary 
structures are indicated above the sequences, and residues forming the hydrophobic H3K9me3 binding pocket [5] are highlighted in turquois. 
Citrullinated residues are highlighted in pink. The right panel shows an X-ray crystal structure of the HP1γ CD in complex with H3K9me3. PDB file 
‘5tli’ was adapted using Pymole. Residues forming the hydrophobic pocket are highlighted in turquois and citrullinated residues in pink. b/c MS/
MS analysis identifies citrullination of HP1γ at residues R38 and/or R39 in a chromatin fraction of mESCs. Plots show the fragmentation spectra 
of the LysC peptides VLDRRVVNGKVEYFLK (b) and VLDRRVVNGK (c) surrounding arginine (R) 38 and R39 of HP1γ. The y (red) and b (blue) series 
indicate fragments at amide bonds of the peptide. Immonium ions unique for citrulline (Im/(Cit) at m/z 130) and arginine (Im/(Arg) at m/z 129) were 
detected in both peptides
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at R38 and R39 when the protein is bound to H3K9me3 
peptides.
HP1γ citrullination is reduced in differentiating mESCs
Our data indicate that citrullination occurs in HP1γ 
at R38 and R39 (Figs. 1, 3). We next inquired whether 
citrullination of R38 and R39 could be differentially 
regulated in vivo. Citrullination of H1.2 by PADI4 dur-
ing reprogramming of mouse embryonic fibroblasts 
(MEFs) highlights a role for citrullination in regulat-
ing stem cell plasticity [22]. Furthermore, both PADI4 
and HP1γ are involved in regulating the integrity of 
pluripotent stem cells [16, 22]. We therefore assessed 
whether citrullination of HP1γ decreases upon stem 
me3
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Fig. 2 Efficient binding of HP1γ to H3K9me3 requires R38 and R39 in vitro. a Coomassie-blue stained gel showing the results from a pulldown assay 
analysing binding of recombinant GST-HP1γWT and GST-HP1γR38/9A proteins to H3(1–16) peptides or H3K9me3(1–16) peptides, as indicated. 
25% of input amounts are shown. Binding intensities of gel bands from multiple experiments (Additional file 2: Figure S2A) were quantified using 
ImageJ and were normalised to total inputs (right hand graph). Statistical analysis was performed using unpaired, 2 tailed Student’s t-test. Bars 
represent ± SD, n = 3 (*p value: 0.021, **p value: 0.008, ns.: not significant, p value: 0.181). The sequences of the peptides used are indicated at the 
top. b Real-time binding kinetics of GST-HP1γ proteins using bio-layer interferometry (BLI). BLI sensorgrams are shown profiling the normalised 
binding of recombinant GST-HP1γWT and GST-HP1γR38/9A to H3(1–16) peptides (H3: right panel) and H3K9me3(1–16) peptides (H3K9me3: left 
panel), as indicated. Association (30–150 s) and dissociation (150–270 s) were each measured over the course of 120 s. The protein concentrations 
used were WT: 28.0 μM; R38/9A: 28.3 μM. Results of one experiment repeated at a range of different protein concentrations are shown (Additional 
file 2: Figure S2C
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cell differentiation, as would be expected given the 
decrease in PADI4 gene expression during this process 
[22]. We induced differentiation in mESCs cultured 
under serum/LIF by LIF withdrawal for 72 h (Fig. 4a). 
After 72 h, the mRNA levels of the pluripotency mark-
ers Nanog, Klf4 and Oct4 were down-regulated (Fig. 4b) 
which was accompanied by clear morphological 
changes (Fig.  4c), indicating that mESCs were begin-
ning to differentiate. We then immunoprecipitated 
HP1γ from nuclear lysates of mESCs cultured with or 
without LIF. Immunoblotting of the extracts using an 
anti-peptidyl-citrulline antibody showed that HP1γ is 
indeed significantly less citrullinated in differentiat-
ing mESCs (Fig. 4d, Additional file 5: Figure S4A). This 
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Fig. 3 PADI4 citrullinates HP1γ in vitro. a Recombinant GST-HP1γWT, R38K, R39K or R38/9K mutant proteins were incubated with recombinant 
GST-PADI4 in the presence or absence of activating calcium as indicated. Reactions were resolved by SDS-PAGE and analysed by immunoblot 
analysis using an anti-peptidyl-citrulline antibody. Ponceau S staining of the transferred proteins serves as a loading control (lower panel). Bands 
highlighted by the red boxes were quantified using ImageJ. Total intensities after background correction are indicated (right panel). Statistical 
analysis was performed using two-way ANOVA multiple corrections with Sidak post hoc test. Bars represent ± SD, n = 3 (**p values from left to 
right: 0.002, 0.003, 0.008) (Additional file 4: Figure S3A). b GST-HP1γWT or R38/9K mutant proteins were incubated with GST-PADI4, with or without 
calcium, in the presence or absence (w/o) of unmethylated H3(1–16) peptides or H3K9me3(1–16) peptides, as indicated. Ponceau S staining of the 
transferred proteins serves as a loading control (lower panel). Bands highlighted by the red boxes were quantified using ImageJ and background 
corrected. Increased citrullination of HP1γWT in the presence of H3K9me3 peptides compared to unmethylated H3 peptide is displayed as fold 
change intensity (right panel). Statistical analysis was performed using unpaired Student’s t test. Bars represent ± SD, n = 3 (**p value: 0.004) 
(Additional file 4: Figure S3B)
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finding not only validates the identification of HP1γ 
citrullination in our MS analysis (Fig.  1), but more 
importantly indicates that citrullination is a dynamic 
post-translational modification of HP1γ with a poten-
tial role in regulating stem cell plasticity.
Mutations of HP1γ R38 and R39 do not affect soluble 
diffusion rate
HP1γ R38 and R39 are important for binding to 
H3K9me3 peptides in  vitro (Fig.  2). We then assessed 
whether citrullination of R38 and R39 affects asso-
ciation of HP1γ to chromatin in live mESCs upon LIF 
withdrawal. To analyse HP1γ dynamics in vivo, we used 
single-particle tracking of HP1γ in mESCs cultured in 
the presence and absence of LIF. However, although HP1 
dynamics have been well characterised using numer-
ous techniques over many years [26–29], the technique 
described here has not previously been used to moni-
tor the diffusion and binding kinetics of HP1 molecules 
in live cells. Therefore, as a proof of principle, we tested 
this technique by comparing wildtype HP1γ (HP1γWT) 
to the well-characterised chromoshadow domain (CSD) 
mutant HP1γI165K, which prevents dimerisation of 
HP1γ [30]. We generated mESC lines stably expressing 
HP1N terminally tagged with the photo-activatable fluo-
rophore mEos3.2 [31] fused to a HaloTag [32] (Fig.  5a). 
Expression of fusion proteins was confirmed by immuno-
blot analysis (Additional file 6: Figure S5A).
Tagged HP1γ molecules were labelled using low con-
centrations of HaloTag–JF549 ligand [33], and dynam-
ics were measured in mESCs at 13.5 ms time resolution. 
Jump distance analysis as illustrated in Fig.  5a, b [34] 
showed that both WT and CSD mutant molecules exhibit 
two major diffusion coefficients (bound and diffusing) 
(Additional file 6: Figure S5B and C). This corresponds to 
published results using fluorescence correlation spectros-
copy (FCS) of GFP-tagged HP1 proteins [28, 29]. Whilst 
diffusion coefficients of bound molecules remained 
unchanged for HP1γI165K mutant proteins, diffusing 
mutant molecules moved significantly more quickly than 
wildtype molecules (Additional file  6: Figure S5D to F, 
Additional file  7: Table  S2). Overall, these results con-
firm previously published experiments employing fluo-
rescence recovery after photobleaching (FRAP) of HP1 
d
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Page 7 of 17Wiese et al. Epigenetics & Chromatin           (2019) 12:21 
CSD mutants in both heterochromatic and euchromatic 
regions in vivo [26] and validate SPT as a suitable tech-
nique to detect differences in HP1 mobility.
Given the success of the above proof of principle exper-
iments, we next compared mESCs (+/− LIF) expressing 
HP1γWT protein with cells expressing HP1γR38/9A, 
mimicking citrullinated HP1γ. Importantly, exogenous 
expression of HP1γ proteins had no discernible effect on 
mESC differentiation as (i) ground state mRNA levels of 
the pluripotency markers (Additional file 5: Figure S4B); 
(ii) down-regulation of mRNA levels of the pluripotency 
markers after LIF withdrawal (Additional file  5: Figure 
S4C); and (iii) morphological changes after LIF with-
drawal (Additional file  5: Figure S4D) in mESCs stably 
expressing either HP1γWT or HP1γR38/9A mutant pro-
teins did not differ from those of parental mESCs.
We observed increased HP1γ foci formation in dif-
ferentiating cells by fluorescence imaging of mEos3.2 
(Fig.  5c), confirming a previous study using the same 
differentiation protocol [35]. However, no appar-
ent difference was detected between HP1γWT- and 
HP1γR38/9A-expressing cells. Similarly, SPT analyses 
of either HP1γWT or HP1γR38/9A mutant proteins 
showed that LIF withdrawal had no significant effect on 
their diffusion rate in mESCs (Fig. 5d–f, Additional file 7: 
Table S2). These results indicate that the diffusion of sol-
uble HP1γ molecules is not affected by LIF withdrawal 
and it does not depend upon R38 and R39.
HP1γ R38 and R39 determine chromatin residence time 
in differentiating mESCs
Although HP1 is a multifunctional protein, its best-
characterised function is its ability to specifically bind 
to H3 tails harbouring H3K9me3. This underpins the 
establishment of localised, as well as higher-order, chro-
matin domains. Indeed, binding of structural chro-
matin proteins, such as HP1, is crucial in establishing 
heterochromatin during stem cell differentiation [2]. 
We therefore decided to focus on the chromatin bound 
fraction of HP1γ. We used a concept called motion blur-
ring in which long exposures are used to blur molecules 
that are diffusing so they are not detected. Therefore, 
only molecules bound throughout the long exposure 
are imaged [32, 36, 37]. We performed SPT at 500  ms 
time resolution of mESCs expressing either HP1γWT or 
HP1γR38/9A mutant proteins (−/+ LIF). Movies of rep-
resentative cells are shown in Additional file 8: Movie S1, 
Additional file 9: Movie S2, Additional file 10: Movie S3, 
and Additional file  11: Movie S4. Motion blurring anal-
ysis revealed that HP1 molecules bound to chromatin 
possess two main residence times which we will refer to 
as specific and unspecific residence times (Fig. 6a, Addi-
tional file 12: Figure S6, Additional file 7: Table S2).
Whilst LIF withdrawal had no effect on the unspecific 
residence time of either HP1γWT or HP1γR38/9A mol-
ecules, the specific residence time of HP1γWT molecules 
was significantly increased (20 s longer upon differentia-
tion, Fig. 6b, d). In stark contrast, the specific residence 
time of R38/9A mutant HP1γ molecules was consider-
ably shorter (Fig. 6b, d). Consequently, the average time 
that HP1γR38/9A molecules remain stably bound to 
chromatin in differentiating mESCs is significantly lower 
than for HP1γWT molecules (29.5 ± 4.1 vs. 49.2 ± 12.3 s 
(Fig. 6b, d)).
On the basis of these results, we conclude that HP1γ 
residues R38 and R39 are not critical for HP1 recruit-
ment to chromatin during stem cell differentiation, 
because diffusion of soluble HP1γ molecules remained 
unchanged upon LIF withdrawal. However, the two resi-
dues influence the overall stability of HP1γ molecules 
bound to chromatin in differentiating mESCs.
(See figure on next page.)
Fig. 5 Mutation of HP1γ R38 and R39 does not affect diffusion rate of diffusing molecules. Statistical analyses were performed using two-way 
ANOVA multiple corrections with Sidak post hoc test. mESCs were cultured +/− LIF for 72 h. a Schematic illustration of mEos3.2–HaloTag–HP1 
fusion proteins used for single-particle tracking (left panel). X-ray crystal structures of green EosFP (PDB_1ZUX) and HaloTag (PDB_5UXZ) are 
shown together with the chemical structure of  JF549 dye coupled to the HaloTag-chloroalkane linker. Right panel shows schematic illustration 
of jump distance (JD) analysis of single-particle tracking (SPT) data to determine diffusion coefficients (d). JD analysis plots a histogram of all 
particle displacements within a fixed time interval Δt for all trajectories. Fitting the distribution of displacements yields the minimum number of 
diffusion coefficients needed to describe the motion of the particles. b Representative mEos3.2 fluorescent images at 488 nm excitation of mESCs 
expressing mEos3.2–HaloTag–HP1WT and single molecule tracks of HaloTag–JF549-tagged molecules are shown. Bound and diffusing molecules 
are highlighted. c Representative mEos3.2 fluorescent images of mESCs expressing mEos3.2–HaloTag–HP1γWT and HP1γR38/9A. Scale bar: 2 μm. 
d/e SPT of mEos3.2–HaloTag–HP1γWT and HP1γR38/9A in mESCs. d Cells were labelled with HaloTag–JF549 ligand and subjected to 2D SPT. At 
561 nm, fluorescent images were collected as movies of 10,000 frames at 13.5 ms time resolution. Plot depicts diffusion coefficients (D) [μm2 s−1] 
of the indicated HP1 molecules. Bars represent ± SD (n = 5–9). Multiple comparisons resulted in no significant differences across conditions (ns. p 
values > 0.999). e Percentages of molecules within diffusing and bound fractions (ns. p values > 0.967). f Tabulated summary of results shown in d 
and e 
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Discussion
Our findings are consistent with a model in which HP1γ 
in pluripotent mESCs is citrullinated by PADI4 to reduce 
its affinity to chromatin (Fig. 7). This may explain, at least 
in part, how a relatively open chromatin conformation is 
maintained in pluripotent mESCs. Upon differentiation, 
PADI4 expression decreases [22] together with the levels 
of HP1γ citrullination (Fig. 4d) promoting its interaction 
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with chromatin (increased specific residence time of 
HP1γ—(Fig. 6b, d)). This could help to establish hetero-
chromatin domains and/or regulate specific gene expres-
sion programs during stem cell differentiation. Indeed, a 
similar non-mutually exclusive mechanism was recently 
reported for H1, which is also citrullinated by PADI4 
[22].
Our finding that PADI4-mediated citrullination of 
HP1γ is significantly increased when HP1γ is bound to 
H3K9me3 peptides supports the notion that HP1γ is tar-
geted by the deiminase when bound to chromatin. An 
X-ray crystal structure of HP1γ’s chromodomain bound 
to H3K9me3 (Fig. 1a) indicates that R38 and R39 are fac-
ing away from the H3K9me3 binding pocket, suggesting 
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Fig. 6 HP1γ R38 and R39 influence chromatin residence time in differentiating mESCs. Statistical analyses were performed using two-way ANOVA 
multiple corrections with Sidak post hoc test. mESCs were cultured +/− LIF for 72 h. a Schematic illustration of HP1γ dynamics in mESCs. SPT of 
mEos3.2–HaloTag–HP1γ molecules at 13.5 ms time resolution determines two fractions with individual diffusion coefficients: diffusing and bound. 
SPT at 500 ms time resolution allows further detection of molecule dynamics within the bound fraction (~ 37.4% of all detectable HP1γ molecules). 
Within the bound fraction, two populations with individual residence times (tres) [s] are detected: unspecific (tres = 2.4 s) and specific (tres = 28.8 s). 
b/c SPT of mEos3.2–HaloTag–HP1γWT and HP1γR38/9A in mESCs. b Cells were labelled with HaloTag–JF549 ligand and subjected to SPT. At 561 nm, 
fluorescent images were collected as movies of 1000 frames at 500 ms time resolution. Left panel depicts the  tres for specific and unspecific binding 
of the indicated HP1 molecules. Bars represent ± SD (n = 3) (*p value left to right = 0.027, 0.036; ns. p value > 0.841). C Percentages of molecules with 
unspecific and specific tres. d Tabulated summary of results shown in b and c. Errors represent ± SD (n = 3)
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the residues are accessible to be targeted by an enzyme. 
However, to fully understand how PADI4 targeting is 
achieved structurally, biophysical analyses such as X-Ray 
crystallography or NMR of the enzyme in complex with 
H3K9me3 bound HP1γ will be required.
Given our in  vitro citrullination data, we hypothesise 
that HP1γ citrullination may represent a relatively rare 
modification occurring at specific genomic loci to which 
PADI4 is recruited. Thus, HP1γ’s residence time would 
be affected by citrullination at specific genomic loci. In 
fact, our MS analysis assessed the stoichiometry of HP1γ 
citrullination in mESCs to be in the very low percent-
age range, which was supported by our immunoblotting 
experiments which detected relatively low levels of HP1γ 
citrullination in mESCs (Fig. 4d). Given this, we believe 
that the citrullination of HP1γ acts to regulate its chro-
matin binding at specific genomic sites, possibly at genes 
controlling cellular plasticity.
Citrullination of histone H3R8 by PADI4 at gene pro-
moters reduces the binding affinity of HP1 to adjacent 
methylated H3K9 which results in gene activation [38]. 
It is possible that PADI4 targets both H3R8 and HP1γ 
bound to the same H3N-terminal tail. The Nanog gene 
may represent an important example of such a locus, 
since chromatin immunoprecipitation experiments have 
shown that both HP1γ and PADI4 bind to its promoter 
and regulate gene expression in stem cells [16, 22].
Additional support of our model stems from a pro-
teomics study demonstrating HP1γ is predominantly 
nucleoplasmic in mESCs, with only a small fraction sta-
bly bound to chromatin [39]. In contrast, in cells with 
less pluripotent potential, HP1γ is more chromatin 
bound and predominantly interacts with H1(39), which 
itself is more chromatin bound [22] (Fig. 7).
HP1 proteins possess domains that allow interaction 
with chromatin in a multivalent fashion (reviewed in 
[40]). Here, we have shown that single-particle track-
ing can be used to reliably measure HP1 dynamics in 
live cells. Given the significant increase in diffusion of 
fast moving HP1 molecules after mutating the CSD, it 
is highly likely that HP1 molecules move and associ-
ate with chromatin as dimers and/or as part of larger 
protein complexes. The recently discovered ChAHP 
complex, comprised of transcription factor ADNP, 
chromatin remodeler CHD4 and HP1, plays a crucial 
role in transcriptionally regulating cell fate decisions 
[41]. Hence, it will be interesting to investigate how this 
protein complex affects HP1 dynamics in stem cells.
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Fig. 7 Working model depicting a role for HP1γ R38 and R39 during stem cell differentiation. In pluripotent stem cells, HP1γ proteins bound to 
specific genomic loci (e.g. Nanog promoter) are citrullinated (cit) by PADI4 to reduce their affinity to chromatin, whilst the diffusion of soluble HP1γ 
molecules is not affected. This may explain, at least in part, how a relatively open chromatin conformation at specific gene loci and potentially 
expression of pluripotency genes in stem cells is maintained. A similar (non-mutually exclusive) mechanism was identified for H1 [22], which 
interacts with HP1γ in stem cells with reduced pluripotent potential [39]. Upon differentiation, PADI4 expression decreases and the subsequent 
reduction in HP1γ citrullination would promote its interaction with chromatin (increased specific residence time) which may result in chromatin 
compaction and/or changes in gene expression
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Finally, it is currently unclear whether citrullination 
of HP1γ is involved in the reprogramming of cells to a 
more plastic state. However, this seems plausible since 
loss of HP1γ increases the reprogramming efficiency of 
mouse embryonic fibroblasts [16].
Conclusion
Our work identifies citrullination of HP1γ within its 
chromodomain as a novel post-translational modification 
in mESCs that is dynamically regulated during mESC dif-
ferentiation. The arginines that are citrullinated within 
the chromodomain directly affect H3K9me3 binding 
in vitro and influence the overall stability of HP1γ mol-
ecules bound to chromatin in differentiating mESCs. 
Overall, our data highlight citrullination of HP1γ as a 
mechanism facilitating mESC differentiation.
Materials and methods
Mass spectrometry and identification of citrullinated 
peptides
Previously published tandem mass spectrometry data 
of mESCs [22] were re-analysed using an improved 
search algorithm. Mass spectrometry data analysis was 
performed with the MaxQuant software suite (version 
1.2.6.20) as described [43] supported by Andromeda 
(www.maxqu ant.org) as the database search engine for 
peptide identifications [44]. We followed the step-by-step 
protocol of the MaxQuant software suite [45] to generate 
MS/MS peak lists that were filtered to contain at most six 
peaks per 100-Da interval and searched by Andromeda 
against a concatenated target/decoy [46] (forward and 
reversed) version of the Uniprot human database ver-
sion (70.101 forward protein entries). Protein sequences 
of common contaminants such as human keratins and 
proteases used were added to the database. The initial 
mass tolerance in MS mode was set to 7 ppm, and MS/
MS mass tolerance was set to 20  ppm. Cysteine carba-
midomethylation was searched as a fixed modification, 
whereas protein N-acetylation, oxidised methionine, 
deamidation of asparagine and glutamine, and citrullina-
tion of arginines were searched as variable modifications. 
A maximum of two miscleavages was allowed whilst 
we required strict LysC specificity. Peptide assignments 
were statistically evaluated in a Bayesian model on the 
basis of sequence length and Andromeda score. We only 
accepted peptides and proteins with a false discovery rate 
of < 1%, estimated on the basis of the number of accepted 
reverse hits.
Modification sites within peptide sequences were 
assigned by calculating the localisation post-transla-
tional modification (PTM) score, which is a probabil-
ity-based scoring system implemented in MaxQuant 
software suite and the Andromeda search engine, 
described previously. The score is based on the so-
called MS3 scoring algorithm initially developed for the 
assignment of phosphorylation sites [47]. Briefly, the 
algorithm makes use of the 10 most intense fragment 
ions per 100 amu in an acquired tandem mass MS/MS 
spectrum. It then calculates the putative fragment ions 
(b- and y-ions for HCD fragmentation) in the observed 
mass range for all possible combinations of modifica-
tion sites in a peptide sequence and determines the 
number of matches, k. The localisation PTM probability 
score is then derived based upon −10× log10(p) , where 
the probability p is calculated as
Mammalian and bacterial expression constructs
The vector pSB7 was generated from the pEF/myc/ER 
backbone (Invitrogen) by replacing myc/ER regula-
tory elements with the sequence encoding mEos3.2–
HaloTag. Mouse HP1γ cDNA was cloned into Xho1/
Xba1 restriction sites of the mammalian expression 
vector pSB7 and into BamH1/EcoR1 restriction sites 
of the bacterial expression vector pGEX-2T. Point 
mutants were generated using Quick change II site-
directed mutagenesis kit (Stratagene). Bacterial expres-
sion vector pGEX6p-GST-hPADI4 was described 
previously [22].
Immunoblotting and antibodies
For immunoblotting, cells were lysed in 2 × Laemmli 
buffer and sonicated in a water bath (Fisherbrand) for 
3  min to shear genomic DNA, spun down at full speed 
in a microfuge for 15  min and incubated for 5  min at 
95 °C. Proteins were resolved by SDS-PAGE, transferred 
to nitrocellulose membrane (Millipore) using wet trans-
fer (transfer buffer: 192  mM glycine, 25  mM Tris.HCl 
pH8.8) and incubated in blocking solution (5% BSA in 
TBS containing 0.5% Tween-20 for citrulline sensitive 
antibodies and 5% non-fat milk powder in TBS contain-
ing 0.1% Tween-20 for all other antibodies) for 1  h at 
room temperature (RT). Membranes were incubated 
with primary antibody at 4 °C o/n and appropriate HRP-
conjugated secondary antibody for 1 h at RT. Membranes 
were then incubated for enhanced chemiluminescence 
(ECL, Promega), and proteins were detected by expo-
sure to X-ray film or using the ChemiDoc™ MP imaging 
system (Bio-Rad). Images were quantified using ImageJ 
analysis software. Primary antibodies diluted in blocking 
p =
(
k!
(n!(n− k)!
)
× pk × (1− p)(n− k)
=
(
k!
(n!(n− k)!
)
× 0.04k
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solution were used to detect citrullinated histone H3R2 
(H3R2-Cit, Abcam ab176843 at 1:1000 dilution), HP1γ 
(Millipore 05-690 MAB clone 42s2 [16] at 1:1000 dilu-
tion), β-Tubulin (Abcam ab6046 at 1:1000 dilution) and 
peptidyl-citrulline (Millipore MABN328, clone F95 [48] 
at 1:1000 dilution). HRP-conjugated secondary antibod-
ies diluted in blocking solution were used against mouse 
IgG (Dako, P0447 at 1:5000 dilution), rabbit IgG (Abcam, 
ab6721 at 1:20,000 dilution) and sheep IgG (Abcam, 
ab6747 at 1:5000 dilution).
Antibody purification from crude sera
Site-specific citrulline antibodies against HP1γ R38/9-
citrulline were raised by Orygen Antibodies Ltd. Sheep 
were immunised with HP1γ peptides (aa 34–44) citrul-
linated at residues 38 and 39 (KVLD(Cit)(Cit)VVNGKC) 
that was C-terminally coupled to KLH. After the initial 
immunisation, 3 boost injections every 4  weeks were 
performed. Crude serum of the final bleed was puri-
fied against the HP1γ R38/9-citrulline peptide (same 
as immunogen) columns. In brief, peptides were first 
reduced using Bond-Breaker™ TCEP Solution (Ther-
mofisher Scientific) and then coupled to SulfoLink™ 
Coupling Resin (Thermofisher Scientific) according to 
the manufacturer’s instructions. Non-specific bind-
ing of the column was blocked using quenching reagent 
(50  mM l-cysteine in coupling buffer), followed by 3 
washes in wash buffer (1  M NaCl in  H2O) and twice in 
1xTBS. Crude serum was centrifuged at maximum speed 
for 10 min; supernatant was added to the resin and incu-
bated at RT for 1 h on a rotating wheel. Resin was then 
washed 4x in 1xTBS. To elute the antibodies, elution 
buffer (0.2  M glycine HCl pH 2.5) was added and tube 
was quickly flicked and directly centrifuged at 800  rpm 
for 1  min. Supernatant was moved to a fresh tube and 
placed on ice. Immediately ice-cold neutralisation buffer 
(1 M Tris HCl pH 8.8) was added and mixed thoroughly 
to neutralise the pH to 7.
Dot blot assay
Dot blot assays were performed by spotting synthetic pep-
tides (HP1γ (34–44) unmodified: KVLDRRVVNGKC; 
HP1γR38Cit: KVLD(Cit)RVVNGKC; HP1γR39Cit: 
KVLDR(Cit)VVNGKC; HP1γR38/9Cit KVLD(Cit)(Cit)
VVNGKC; HP1γ (104–111) R108Cit: SKKK(Cit)DAADKC; 
HP1α (103–112) R107Cit SKKK(Cit)EQSNDC) onto pre-
wet PVDF membranes. Membranes were blocked in 5% 
BSA blocking buffer for 1  h at RT. Blocked membranes 
were then probed with the affinity purified HP1γR38/9-Cit 
antibody (at 1:500 dilution) at 4  °C o/n. Membranes were 
washed 3 times for 30  s in TBS with 0.1% Tween-20 fol-
lowed by another 10 min wash in the same buffer to remove 
residual antibodies. Membranes were then incubated 
in appropriate secondary antibodies and developed as 
described in “Immunoblotting and antibodies” section.
Immunoprecipitation
mESCs were either cultured under serum/LIF conditions or 
without LIF for 72 h. 2 × 107 cells were harvested, washed 
twice in ice-cold 1xPBS and lysed in 1 ml of nuclear lysis 
buffer (NLB: 10 mM Hepes KOH pH 7.9, 1.5 mM  MgCl2, 
10 mM KCl, 0.5 mM DTT, 0.1% NP-40 supplemented with 
cOmplete™ proteinase inhibitor cocktail (Roche)). Lysate 
was incubated for 10 min on ice, and nuclei were pelleted 
at 2000  rpm for 10  min. Nuclear pellet was washed in 
NLB and lysed in 0.5 ml 1 × RIPA buffer (10 mM Tris pH 
8.0, 1  mM EDTA, 1% Triton X-100, 0.1% sodium deoxy-
cholate, 0.1% SDS, 140  mM NaCl) Supplementaled with 
cOmplete™ proteinase inhibitor cocktail (Roche)). The 
lysate was incubated on ice for 20 min with vortexing every 
5 min and centrifuged at full speed for 15 min to remove 
cellular debris. 2  μg of HP1γ antibody (Millipore 05-690 
MAB clone 42s2) or an isotype control (Abcam, HA.C5, 
ab18181) was added and incubated at 4 °C overnight on a 
rotating wheel. 30  μl of Protein G  Dynabeads® (Thermo 
Fisher Scientific) was added and incubated for 2 h at 4 °C 
on a rotating wheel. Beads were washed 3 ×  in ice-cold 1× 
RIPA, lysed in 2 × Laemmli buffer, resolved by SDS-PAGE 
and subjected to immunoblotting.
Purification of recombinant GST‑hPADI4 and in vitro 
deimination assay
Recombinant human GST-PADI4 was expressed from 
pGEX6p constructs [22] in  LBAmp media, induced with 
0.1 mM IPTG at 30 °C for 4 h, purified using glutathione-
Sepharose resin, eluted using a 25 mM glutathione solution 
and stored in 20% glycerol at − 20 °C. In vitro deimination 
of GST-HP1 variants was carried out as described previ-
ously [22]. In vitro deimination assays were performed in 
the presence and absence of 100 ng H3(1–16) or H3K9me3 
peptides as appropriate. Samples were resuspended in 
1 × Laemmli buffer for immunoblot analysis.
Bio‑layer interferometry (BLI)
Recombinant mouse full-length HP1 wildtype and 
mutant proteins were expressed in (as GST fusion pro-
teins), and purified from, Escherichia coli as described 
[4]. Proteins were concentrated using Amicon Ultra 
centrifugation filters with a 30  kDa cutoff (Millipore), 
washed into binding buffer (20  mM Hepes KOH pH 
7.2, 70  mM KCl, 1  mM DTT, 0.1% Tween-20, 5% glyc-
erol). Protein concentrations were determined by Brad-
ford protein assay against a BSA standard, and purity 
was verified by SDS-PAGE followed by Coomassie-blue 
staining. Real-time binding assays of GST-HP1γ were 
performed using the  BLItz® system (ForteBio) in binding 
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buffer (+ 0.1% BSA). Biotinylated H3(1–16) peptides 
 (NH2-ARTKQTARK(me3)STGGKAP-Biotin) were 
immobilised to Dip and Read High Precision Streptavidin 
(SAX) Biosensors (ForteBio), and kinetics for a range of 
protein concentrations were measured under advanced 
kinetics settings (1. initial baseline measuring buffer 
only: 30  s, 2. loading of peptides onto sensors: 120  s, 3. 
effective baseline measurement: 30  s, 4. association of 
GST-HP1γ proteins: 120 s, 5. dissociation of GST-HP1γ 
proteins: 120 s). The data were normalised to the effective 
baseline signal by subtracting the average baseline value 
(150–180 s) from each data point (150–420 s). Values of 
1. and 2. measurements were not included in analysis and 
are not displayed in figures. Raw data are summarised in 
Additional file 3: Table S1.
Peptide pulldown assay
H3K9me3 or unmethylated H3(1–16) peptides, linked to 
Dynabeads MyOne streptavidin T1 (Thermo Fisher Scien-
tific), were used in pulldown assays with eluted GST-HP1 
in HBS-EP (300 mM NaCl, 10 mM HEPES KOH pH 7.4, 
5 mM EDTA and 0.2% NP-40). Pulldown assays were per-
formed in 300 mM NaCl HBS-EP as previously described 
[4]. Samples were resuspended in 2 × Laemmli buffer and 
resolved by SDS-PAGE followed by Coomassie-blue stain-
ing. Images were quantified using ImageJ software.
Cell culture
Parental E14 mouse embryonic stem cell (mESC) line 
was profiled by transcriptome analysis, qPCR and 
potency assays [22] and was routinely tested for myco-
plasma contamination and tested negative. Cells were 
cultured in DMEM (Gibco) supplemented with 15% 
standard FCS (Gibco), 0.1  mM non-essential amino 
acids (Gibco), 1% penicillin/streptomycin, 2  mM l-glu-
tamine (Gibco), 1 mM sodium pyruvate (Gibco), 0.1 mM 
β-mercaptoethanol (Life Technologies) and  106 units/l 
mLIF (ESGRO, Millipore). E14 cells were stored in 
incubators at 37  °C in 7.5%  CO2 (100% humidity) and 
maintained in 0.1% gelatin coated 10-cm culture dishes 
with 1:6 passaging every 2  days. Media was changed 
on a daily basis. E14 ESCs expressing mouse mEos3.2–
HaloTag-HP1 fusion proteins were generated by trans-
fecting appropriate pSB7 plasmids into E14 cells using 
Lipofectamine 2000 transfection reagent (Invitrogen), 
followed by selection in 600 µg/ml geneticin (Life Tech-
nologies). After 2 weeks of geneticin selection, cells were 
sorted using a Sony SH800S cell sorter for the expression 
of mEos3.2. Differentiation of ESCs was induced by LIF 
withdrawal. ESCs cultured in complete ES cell media 
(+ LIF) were trypsinised and washed twice in 1x PBS to 
remove residual LIF, seeded into ES cell media without 
LIF and incubated for 24, 48 or 72 h.
cDNA synthesis and RT‑PCR
Cells were lysed using  QIAzol® lysis reagent (Qiagen) 
and total RNA was isolated using  RNeasy® Mini Kit with 
in column DNase treatment (Qiagen). 1 μg of total RNA 
was reverse-transcribed using Superscript III Reverse 
Transcriptase kit (Invitrogen). Samples were diluted 1:10 
in nuclease-free water prior to RT-PCR analysis. RT-
PCR reactions were performed in duplicates for each 
sample. Each RT-PCR reaction was performed in a final 
volume of 10 μl. Fast SYBR Green Master Mix (Applied 
Biosystems) was used, according to the manufacturer’s 
instructions. A melting curve was obtained for each 
PCR product after each run, in order to confirm that the 
SYBR Green signal corresponded to a unique and spe-
cific amplicon. Relative expression was calculated with 
the  2−ΔΔCt method, normalising to the housekeeping 
gene β-actin. Data were analysed using GraphPad Prism 
7 software. Primers used in this study are summarised in 
Additional file 13: Table S3.
Microscope setup
An IX73 Olympus inverted microscope was used with cir-
cularly polarised laser beams aligned and focused at the 
back aperture of an Olympus 1.40 NA 100 × oil objective 
(Universal Plan Super Apochromat, 100 × , NA 1.40, UPL-
SAPO100XO/1.4). Continuous wavelength diode laser 
light sources used include a 561-nm (Cobolt, Jive 200, 200 
mW) and a 405-nm laser (Stradus, Toptica, 405–100, 100 
mW). Oblique angle illumination was achieved by align-
ing the laser off axis such that the emergent beam at the 
sample interface was near-collimated and incident at an 
angle slightly less than the critical angle θc ~ 67° for a glass/
water interface. This generated a ~ 50  μm diameter exci-
tation footprint. The power of the collimated beams at 
the back aperture of the microscope was 10 kW/cm2 and 
10–100 W/cm2 for the 561-nm and 405-nm laser beams, 
respectively. The lasers were reflected by dichroic mir-
rors (Semrock, Di01-R405/488/561/635). The fluores-
cence emission was collected through the same objective 
and then further filtered using a combination of long-pass 
and band-pass filters (BLP01-561R and FF01-587/35 for 
561  nm excitation). The emission signal was projected 
onto an EMCCD (Photometrics, Evolve 512 Delta) with an 
electron multiplication gain of 250 ADU/photon operating 
in a frame transfer mode. The instrument was automated 
using the open-source software micromanager [49], and 
the data were displayed using the ImageJ software.
Mammalian live‑cell single‑molecule imaging and analysis
mESCs expressing mEos3.2–HaloTag-tagged HP1γ were 
passaged 2 days before imaging onto 35-mm glass bottom 
dishes No 1.0 (MatTek Corporation P35G-1.0-14-C Case) 
in phenol red-free serum and LIF conditions, if not stated 
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otherwise. Just before single-particle tracking (SPT) 
imaging experiments, cells were labelled with 0.5  nM 
HaloTag–JF549 ligand for at least 15 min, followed by two 
washes in PBS and a 30-min incubation at 37 °C in media, 
before imaging the cells in fresh phenol red-free serum 
and LIF conditions. Cells were under-labelled to pre-
vent overlap of fluorophores during SPT. Using 561  nm 
excitation, fluorescence images were collected as mov-
ies of 10,000 frames at 13.5  ms or 1000 to 5000 frames 
at 500 ms exposure. For live-cell tracking, data were col-
lected for three biological replicates on separate dishes 
and the average values compared. Experiments carried 
out on two separate days showed similar trends.
Live-cell 13.5-ms single-molecule traces were ana-
lysed using software that detects single-molecule trajec-
tories from SPT movies [34]. Briefly, the code detected 
puncta positions in each image frame using a brightness-
weighted centroid after applying a band-pass filter to 
remove low-frequency background and high-frequency 
noise from the image data. To track the HP1 single mol-
ecules, only fluorescent puncta smaller than 3 pixels and 
with a signal to noise greater than 8 were analysed. Fluo-
rescent puncta were considered to be the same molecule 
if they were within 6 pixels (936 nm) between frames. We 
collected more than 5000 single-molecule trajectories 
from single-molecule movies of HP1γWT, HP1γI165K 
and HP1γR38/9A molecules detected within an ROI of 
an average of 3–4 cells. Given we observed an increase in 
diffusion coefficient of the fast sub-population of HP1WT 
molecules compared to the CSD mutants (63% of mol-
ecules for HP1γWT), this is an appropriate sample size to 
demonstrate the change we observe. 13.5-ms SPT experi-
ment (i) was recorded in 1 day, and repeat experiments 
(n = 2–9, number of replicates varies between cell lines) 
were recorded on a different day over the course of 5 days. 
500-ms data repeat experiments (n = 3) were recorded on 
three different days. Independent replicates were com-
pared using two-way ANOVA multiple corrections with 
Sidak post hoc test. This is justified because the variances 
calculated were similar between samples.
Live-cell 500-ms single-molecule traces were analysed 
using Rapidstorm software that determines single-mol-
ecule localisations from PALM movies [50], after using 
ImageJ’s rolling back background correction with a radius 
of 5 pixels. Only fluorescent puncta less than 3 pixels 
wide with a fixed global threshold above 25,000 were ana-
lysed. We collected more than 1000 single-molecule tra-
jectories from single-molecule movies of HP1γWT and 
HP1γR38/9A molecules before and after mESC differen-
tiation. Given we observed an increase in the residence 
time of the stable binding HP1γWT molecules (10–13% 
of molecules), this is an appropriate sample size to dem-
onstrate the change we observe.
Data were fit 1000 times after which the mean of the 
parameters is estimated using the parametric bootstrap 
model:
where fi is the fraction of molecules with a residence time 
of τi. For example, a two-component fit was fit to the 
equation:
where f1 and (1 − f1) are the percentage of molecules with 
residence times of tau1 and tau2.
The code is provided on Github. We determined the 
relative likelihood for each model for each data set by 
use of the Bayesian Information Criterion (BIC) [51] as 
previously described for the case of comparing different 
diffusion models for single-particle tracking data [52]. In 
short, using this approach we calculated the BIC for each 
model from:
where n is the number of data points, p is the number of 
free parameters for the fit and RSS is the residual sum of 
squares of the fit. The fit with the lowest BIC was used 
(Additional file  12: Figure S6). The average values were 
then calculated from the fits of three independent bio-
logical replicates and compared. A Z-test was used to 
calculate the p values because the means are normally 
distributed and showed similar variance.
Additional files
Additional file 1: Figure S1. Citrullination of HP1γ identified by MS/
MS. A Multiple sequence alignment of paralogues of mouse HP1 protein 
sequences using Clustal Omega. Functional domains of HP1 (CD, HR 
and CSD) and C-terminal and N-terminal extensions are colour-coded as 
indicated in panel D. Isoleucine residues in the P × V × L motif, known to 
diminish dimerisation of HP1, are highlighted in yellow. B/C MS/MS frag-
mentation tables relating to the fragmentation spectra depicted in Fig. 1B 
and C, including the mass accuracies of identified fragments. D Schematic 
illustration of HP1γ mutants used in this study. Changes in amino acids 
are indicated. Functional domains of HP1 are illustrated: CD (blue) is 
the chromodomain; HR (orange) is the hinge region; and CSD (green) is 
the chromoshadow domain. C-terminal and N-terminal extensions are 
indicated in grey
Additional file 2: Figure S2. Mutation of R38 and R39 impairs HP1γ’s 
binding to H3K9me3 in vitro. A Unprocessed images of Coomassie-blue 
stained gels showing the results from pulldown assays analysing binding 
of GST-HP1γWT, GST-HP1γR38/9A, GST-HP1γR38/9K, GST-HP1γR38A and 
GST-HP1γR39A mutant proteins to H3K9me3(1–16) or unmethylated 
H3(1–16) peptides, as indicated. 25% of input amounts are shown. (i)–(iii) 
show replicates quantified in Fig. 2A. B BLI sensorgrams showing the nor-
malised binding profiles of recombinant GST-HP1γWT, GST-HP1γR38/9K 
and GST-HP1γR38/9A binding to biotinylated H3K9me3(1–16) pep-
tides. On the left sensorgram, association (30–150 s) and dissociation 
(150–270 s) were each measured over the course of 120 s. Results 
F(t) = Σ fi exp (−t/τi),
F(t) = f1 exp (−t/τ1) +
(
1− f1
)
exp (−t/τ2),
BIC = ln[n](p+ 1)+ n
(
ln
[
2piRSS
n
]
+ 1
)
,
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of one experiment are shown. Protein concentrations used are WT: 
28.0 μM; R38/9K: 25.5 μM; R38/9A: 28.3 μM. C BLI sensorgrams showing 
the normalised binding profiles of recombinant GST-HP1γWT, GST-
HP1γR38/9K, -HP1γR38/9A and GST binding to biotinylated H3 peptides 
(H3K9me3(1–16): left panel) or H3(1–16) peptides (H3: right panel). Asso-
ciation (30–150 s) and dissociation (150–270 s) were each measured over 
the course of 120 s. Results of one experiment are shown. Concentrations 
used from top to bottom were WT: 28.0 μM, 18.7 μM, 12.4 μM, 8.3 μM, 
2.8 μM, 0.9 μM and 0.3 μM; R38/9 K: 25.5 μM, 17.0 μM, 11.3 μM, 7.6 μM, 
2.5 μM, 0.8 μM and 0.3 μM; R38/9A: 28.3 μM, 18.9 μM, 12.6 μM, 8.4 μM, 
2.8 μM, 0.9 μM and 0.3 μM; GST: 30.6 μM, 20.4 μM, 13.6 μM, 9.1 μM and 
3.0 μM
Additional file 3: Table S1. Raw BLI data. Raw BLI data of GST, GST-
HP1γWT, R38/9A and R38/9K proteins at different concentrations to 
H3K9me3(1–16) and H3(1–16) unmethylated peptides
Additional file 4: Figure S3. PADI4 citrullinates HP1γ in vitro. A/B As a 
known PADI4 target, recombinant H3.1 was incubated with recombinant 
PADI4 in the presence of activating calcium. No calcium reactions serve 
as negative controls. Reactions were resolved by SDS-PAGE and analysed 
by immunoblot analysis using (A) an anti-H3R2-citrulline antibody and 
(B) an anti-peptidyl-citrulline antibody (Pan-Cit). C Unprocessed images 
of in vitro citrullination assays relating to Fig. 3A. GST-HP1γWT, GST-
HP1γR38K, GST-HP1γR39K or GST-HP1γR38/9K mutants were treated with 
GST-PADI4 in the presence or absence of activating calcium, as indicated. 
Reactions were resolved by SDS-PAGE and analysed by immunoblot analy-
sis using an anti-peptidyl-citrulline antibody. Images of three biological 
replicates (i–iii) are shown together with their respective ImageJ quantifi-
cations. Quantifications of lanes shown in Fig. 3A are highlighted in red. D 
Dot blot analysis of site-specific polyclonal antibody raised against citrul-
linated mouse HP1γR38/9. Peptides (HP1γ(34–44) unmodified (HP1γ UM), 
double Cit R38/9-Cit (HP1γR38/9-Cit), single Cit R38-Cit (HP1γR38-Cit), 
single Cit R39-Cit (HP1γR39-Cit), single Cit R108-Cit (HP1γ(104–111)R108-
Cit) and single Cit R107-Cit (HP1α(103–112)-R107-Cit)) were immobilised 
on PVDF membranes at indicated amounts (1–125 ng) and incubated 
with a purified HP1γ-R38/9-Cit antibody. E/F Images of in vitro citrullina-
tion assays of GST-HP1γWT or HP1γR38/9K mutant protein treated with 
GST-PADI4 in the presence or absence of activating calcium. Reactions 
were resolved by SDS-PAGE and analysed by immunoblot analysis using 
(E) a purified HP1γ-R38/9-Cit or (F) an anti-peptidyl-citrulline (Pan-Cit) 
antibody. G Unprocessed images of in vitro citrullination assays relating 
to Fig. 3B. GST-HP1γWT or -HP1γR38/9K mutant proteins were treated 
with GST-PADI4, with or without activating calcium, in the presence or 
absence of H3(1–16) or H3K9me3(1–16) peptides, as indicated. Reactions 
were resolved by SDS-PAGE and analysed by immunoblot analysis using 
an anti-peptidyl-citrulline antibody. Images of three replicates (i–iii) are 
shown together with their respective ImageJ quantifications. Quantifica-
tions of lanes shown in Fig. 3B are highlighted in red. Images (i–ii) depict 
autoradiograms whilst image (iii) was acquired using a Chemidoc™ 
imaging system
Additional file 5: Figure S4. Differentiation of mESCs. A Immunoprecipi-
tation (IP) of endogenous HP1γ from nuclear lysates of mESCs before and 
after 72 h LIF withdrawal. IPs were performed with anti-HP1γ and anti-HA 
control antibodies and analysed by immunoblotting using an anti-pepti-
dyl-citrulline antibody (α-Citrulline). Subsequently the same immunoblots 
were stripped and re-probed with an anti-HP1γ antibody (α-HP1γ). 4% of 
input amounts of each IP are indicated. Replicate (i) is shown in Fig. 4D. B 
Stable exogenous expression of mEos3.2–HaloTag–HP1γ fusion proteins 
does not affect total mRNA level of pluripotency markers in mESCs. 
RT-PCR data for the indicated genes were normalised to β-actin mRNA 
expression. Bars represent ± SEM (n = 2). C The mRNA levels of pluri-
potency markers in mESCs decrease after withdrawal of LIF. The mRNA 
levels of the indicated genes were measured by RT-PCR over a course of 
3 days after withdrawal of LIF. RT-PCR data were normalised to β-actin 
mRNA expression, and expression fold change was determined relative 
to  d0 time point using the ddCT method. Bars represent ± SEM (n = 2). D 
Representative light field microscope images of mESCs before and after 
72 h LIF withdrawal, captured with a Leica EC3 camera at 20 × magnifica-
tion. Scale bars: 100 μm
Additional file 6: Figure S5. Single-particle tracking to measure HP1 
dynamics in vivo. A Immunoblot analysis of whole cell extracts of mESCs 
stably expressing or mEos3.2–HaloTag–HP1γWT or fusion proteins. 
Anti-HP1γ antibody detects endogenous and fusion proteins. β-Tubulin 
levels are shown as a loading control. B Representative raw SPT data 
of mEos3.2–HaloTag–HP1γWT and HP1γI165K molecules in mESCs. 
Histograms depict fraction of jumps plotted against jump distance [nm] 
of HaloTag–JF549-tagged HP1 in mESCs. C Representative jump distance 
(JD) analyses of mEos3.2–HaloTag–HP1γWT and I165K molecules in 
mESCs. Cumulative fraction of jumps plotted against JD [μm]. Yellow line 
indicates the result of fit to JDs of bound molecules (D ≤ 0.1 μm2 s−1); 
orange line shows the result of fit to JDs of diffusing molecules (D ≥ 0.6 
μm2 s−1); blue line shows result of fit to JDs combining both bound 
and diffusing molecules; and purple line shows the raw data. D SPT of 
mEos3.2–HaloTag–HP1γWT and HP1γI165K mutant proteins. Cells were 
labelled with HaloTag–JF549 ligand and subjected to SPT. At 561 nm, 
fluorescent images were collected as movies of 10,000 frames at 13.5 ms 
time resolution. Plot depicts diffusion coefficients (D) [μm2 s−1] of the 
indicated HP1 molecules. Bars represent ± SD, n = 4–5, two-way ANOVA 
multiple comparisons with Sidak post hoc test (****p value: 0.0001). E 
Percentages of molecules within diffusing and bound fraction are shown. 
Bars represent ± SD (n = 4–5), two-way ANOVA multiple comparisons with 
Sidak post hoc test (ns. p value > 0.165). F Tabulated summary of results 
shown in D and E. Errors represent ± SD (n = 4–5)
Additional file 7: Table S2. STP data of single replicates. This file contains 
a summary of all biological replicates of analysed STP data of mESCs 
expressing HP1γWT, R38/9A or I165K mutant proteins cultured in the 
presence or absence of LIF for 72 h labelled with HaloTag–JF549 ligand 
imaged at 561 nm at 13.5 and 500 ms time resolution
Additional file 8: Movie 1. SPT of mESC expressing HP1γWT cultured in 
the presence of LIF. Movie of representative mESCs expressing HP1γWT 
cultured in the presence of LIF of experiment (i) labelled with HaloTag–
JF549 ligand imaged at 561 nm. Fluorescent images were collected as 
movies of 1000 frames at 500 ms time resolution
Additional file 9: Movie 2. SPT of mESC expressing HP1γR38/9A cul-
tured in the presence of LIF. Movie of representative mESCs expressing 
HP1γR38/9A cultured in the presence of LIF of experiment (i) labelled with 
HaloTag–JF549 ligand imaged at 561 nm. Fluorescent images were col-
lected as movies of 1000 frames at 500 ms time resolution
Additional file 10: Movie 3. SPT of mESC expressing HP1γWT cultured 
in the absence of LIF. Movie of representative mESCs expressing HP1γWT 
cultured in the absence of LIF for 72 h of experiment (i) labelled with 
HaloTag–JF549 ligand imaged at 561 nm. Fluorescent images were col-
lected as movies of 1000 frames at 500 ms time resolution
Additional file 11: Movie 4. SPT of mESC expressing HP1γR38/9A 
cultured in the absence of LIF. Movie of representative mESCs express-
ing HP1γR38/9A cultured in the absence of LIF for 72 h of experiment 
(i) labelled with HaloTag–JF549 ligand imaged at 561 nm. Fluorescent 
images were collected as movies of 1000 frames at 500 ms time resolution
Additional file 12: Figure S6. HP1γ R38 and R39 determine chromatin 
residence time in differentiating mESCs. Bayesian Information Criterion 
(BIC) of residence time modes. The relative likelihood for each model 
for each data set was determined by use of the BIC comparing different 
models for single-particle tracking data. The fit with the lowest BIC was 
used (light blue). Representative results for experiment (i) are shown as a 
proof of principle. For both HP1γWT and HP1γR38/9A, two binding modes 
were identified as most likely. Parameters describe: tres: residence times; 
a1/(a1 + a2): percentage molecules binding specifically and unspecifically
Additional file 13: Table S3. List of RT-PCR primers used in this study
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